ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2975

Induced Sputum Analysis in Systemic Sclerosis Patients

Irena Litinsky1, Elizabeth Fireman2, Ari Polachek1, Adi Broyde1, Amir Sharabi1, Marina Anouk1, Daphna Paran1 and Ori Elkayam1, 1Rheumatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, 2Institute of Pulmonary and Allergic Diseases, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Induced sputum (IS) is a noninvasive tool, aimed at collecting cellular and soluble materials from lung airways. IS is well accepted by patients, safer than bronchoalveolar lavage (BAL) and easily repeated. IS sampling has been validated in chronic obstructive as well as in various interstitial lung disorders (ILD). Very few studies have evaluated the role of IS analysis in SSc.

 Purpose

To evaluate IS cellular analysis in SSc patients compared to healthy controls and its possible relationship with disease manifestations.

Methods:

Twenty consecutive SSc patients and 16 healthy controls underwent pulmonary Function testing (PFT) (Jaeger Masterlab spirometer), single breath diffusion capacity of carbon monoxide (DLCO) and analysis of induced sputum (IS) cytology. IS was recovered after 20 min inhalation of 3% saline with an ultrasonic nebulizer by the selecting plugs method.

Results:

Group 1(SSc) : 13 (65%) with diffuse type,7 ( 35%) with CREST syndrome,   19 (95%) women,  mean age 52.25+17.08, disease duration  8.69+7.56 years, Raynaud duration 10.3+9.22 years , eight (40%) patients had a history of ILD and none had pulmonary artery hypertension .

.Group 2 (controls): 16 healthy volunteers: 13 women (81.25%), mean age 57.93 ± 10.4years.  

Lung tests:

TLC, FVC and DLCoVA were significantly lower within Group 1 vs controls .  Seven patients in Group1 had a restrictive pattern.

SSc patients IS contained higher neutrophils count (p=0.091) and lower   lymphocytes count (p=0.045) compared to the control group.  No difference in IS cytology was found between types of SSc.

Within Group 1, a statistically significant positive correlation was

found among several clinical, PFT and IS findings (mRss score – CD3 (p=0.044); mRss –CD4 (p=0.04); mRss – % neutrophils (0.059); FVC-% neutrophils (0.002)).  Neutrophils counts in IS were significantly inversely associated with TLC and FVC.

IS samples from SSc patients with PFT restrictive pattern contained a significantly lower percentage of lymphocytes (p=0.004) and CD4/CD8 ratio (0.028) compared with controls.  

Among SSc, the statically significant high CD4/CD8 ratio was associated with restrictive PFT pattern (p=0.05).

A positive correlation was found  between restrictive subtype  of Group 1 IS cytology count  and several clinical, laboratory PFT parameters ( disease duration- CD4/CD8 ratio(p=0.033), TLC- CD3(p=0.053), TLC and FVC  – % macrophages (p=0.033,p=0.052 respectively),  DLCoVA – % macrophages (p=0.032), CRP – % lymphocytes ,% macrophages and neutrophils (p=0.019 and p= 0.008 and p= 0.006 respectively). A Negative correlation was shown between TLC and neutrophils count (p=0.043).

Conclusion:

IS analysis of SSc patients, including patients with restrictive lung disease,  shows changes in cellular pattern in comparison to healthy controls and correlation with several clinical and PFT parameters.


Disclosure: I. Litinsky, None; E. Fireman, None; A. Polachek, None; A. Broyde, None; A. Sharabi, None; M. Anouk, None; D. Paran, None; O. Elkayam, None.

To cite this abstract in AMA style:

Litinsky I, Fireman E, Polachek A, Broyde A, Sharabi A, Anouk M, Paran D, Elkayam O. Induced Sputum Analysis in Systemic Sclerosis Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/induced-sputum-analysis-in-systemic-sclerosis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/induced-sputum-analysis-in-systemic-sclerosis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology